With the advent of legalizing marijuana for recreational use by
Colorado and Washington in 2014 and a growing trend to legalize pot in
some capacity across the nation, there is an increased interest in
addressing drugged driving. The problem is that standardizing policy for
marijuana intoxication is not as simple as just piggybacking
long-established laws for alcohol; more science and research are
required.
In the meantime, technology will be coming to market, such as
the marijuana breathalyzer being developed by Cannabix Technologies,
Inc. (OTC: BLOZF)(CSE: BLO), to give police officers an on-site tool to
enhance detection of THC, the psychotropic metabolite in marijuana. In
the future, devices of this type will likely be dialed in by the
forensic community and become an integral element in identifying
marijuana-intoxicated drivers and in other settings, including workplaces and general consumer use, just as the alcohol breathalyzer is today.
All Blood is Not Drugged Equally
For starters, alcohol affects a person on a first time bender and a
hardened alcoholic in a very similar manner, making breathalyzers
reliable in determining blood alcohol content as evidence to related
laws. Indeed, tolerance and some physical attributes play a role in
alcohol effecting a person, but decades of research support that a blood
alcohol level of 0.08 or above impairs motor and cognitive skills
sufficiently in any person to make them a danger behind the wheel, thus
it is the benchmark for DUI in every state.
Research on the effects of
THC, however, has uncovered mixed results on impairment underpinned in
part by the frequency of pot usage, dissemination of THC throughout the
body and metabolism times, churning debate over DUI laws pertaining to
marijuana. Controversial or not, driving under the influence of
marijuana is still illegal in every state, including many with zero
tolerance, or “per se,” laws.
The Drug Recognition Expert
There is an increasing number of “Drug Recognition Experts,” police officers that go through intensive (and expensive) training for certification to administer a battery of tests to identify people under the influence of different drugs. Governed by the International Association of Chiefs of Police, DRE programs are utilized in both the U.S. and Canada, although the overall number of DREs is relatively low, numbering 6,940 in the U.S. (compared to nearly half a million sworn police officers) and only 480 in Canada at the end of 2012.
DRE evidence has been challenged
several times in the States on its scientific merit, with mostly
limited success, and precedents are set. Even with more DRE’s, police
forces are still in need of an equivalent to the alcohol breathalyzer
for marijuana, a ubiquitous device that can provide non-DRE police with
some immediate evidence of drivers under the effects of THC so that the person may be further evaluated.
Remember in establishing policy for impaired driving under the
effects of alcohol, police were first left to subjective opinions of
physical observations, such as the smell of alcohol on the suspect’s
breath or slurred speech. Blood tests worked to show inebriation, but it
was groundbreaking work
by Dr. Emil Bogen that helped set the stage for modern technology and
alcohol breathalyzers that are a standard in law enforcement.
The Cannabix Breathalyzer
The point here is that the genesis of drunk driving standards
followed a path from subjectivity to science and marijuana policy is
heading down the same route, a fact that doesn’t seem to have eluded Kal Malhi,
President of Cannabix Technologies and a retired member of the Royal
Canadian Mounted Police. Malhi is also the founder of Cannabix
Breathalyzer, Inc., the company that has licensed 100% of the exclusive
North American rights to Cannabix Technologies, effectively giving the
broad investment
community an opportunity to invest in the expanding marijuana market,
including investors uninterested in advocating for the harvest and sale
of marijuana, albeit medicinal or recreational.
Cannabix has been making steady progress in the development of its Cannabix Breathalyzer. A month after it announced
that the prototype’s “mechanical design, circuit board layouts,
firmware, and printed circuit board designs all nearing completion.”, it announced
the completion of an alpha version of the marijuana breathalyzer.
Management plans on evaluating the efficacy of this prototype on medical
marijuana users, as well as making additional improvements to the
device for use as a roadside or workplace drug impairment tool. In the
next beta version, the company will likely begin testing the device with
independent agencies to further evaluate the devices utility in the
field.
Technology Critical to Police
Technology plays a critical role in law enforcement to protect the
public and police officers. This is an expansive arena, including
products such as those manufactured by Taser International
(NASDAQ: TASR)(not just their eponymous non-lethal weapons, but also
their body cameras, etc.), biometric solutions by companies like Aware, Inc.
(NASDAQ: AWRE)(which posted a 41% jump in revenue through the first 9
months of 2014 compared to a year earlier), firearms training simulators
by VirTra Systems (OTC: VTSI) and
much more.
Although it has been illegal all along to drive under the
influence of marijuana, the decriminalization of cannabis has put a
spotlight on drugged driving; expect technology to provide the requisite
tools in this application as well to help police and the justice system
try to keep a thumb on crime.
Recently, CTV National News profiled Cannabix Technology’s Marijuana Breathalyzer, highlighting its promise for law enforcement:
For more information about Cannabix Technologies, visit the company’s website at http://www.cannabixtechnologies.com/.
About CannabisFN
Cannabis Financial Network (CannabisFN) is brought to you by TDM
Financial, a financial media group and owner of SECFilings.com with over
a decade of experience educating investors, profiling public companies,
and developing specific investors audiences. CannabisFN is the largest
dedicated financial network covering the cannabis and medical marijuana
(MMJ) industries and educates investors, business developers and media
on industry news, thought leader and executive perspectives, and the
fluid regulatory environment while serving as a leading corporate
communications platform to public and private companies operating in the
industry.
No comments:
Post a Comment